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ABSTRACT
Background Transnasal endoscopy (TNE) is
performed with an ultrathin scope via the nasal
passages and is increasingly used. This review
covers the technical characteristics, tolerability,
safety and acceptability of TNE and also
diagnostic accuracy, use as a screening tool and
therapeutic applications. It includes practical
advice from an ear, nose, throat (ENT) specialist to
optimise TNE practice, identify ENT pathology and
manage complications.
Methods A Medline search was performed
using the terms “transnasal”, “ultrathin”, “small
calibre”, “endoscopy”, “EGD” to identify
relevant literature.
Results There is increasing evidence that TNE is
better tolerated than standard endoscopy as
measured using visual analogue scales, and the
main area of discomfort is nasal during insertion
of the TN endoscope, which seems remediable
with adequate topical anaesthesia. The diagnostic
yield has been found to be similar for detection of
Barrett’s oesophagus, gastric cancer and GORD-
associated diseases. There are some potential
issues regarding the accuracy of TNE in detecting
small early gastric malignant lesions, especially
those in the proximal stomach. TNE is feasible and
safe in a primary care population and is ideal for
screening for upper gastrointestinal pathology. It
has an advantage as a diagnostic tool in the
elderly and those with multiple comorbidities due
to fewer adverse effects on the cardiovascular
system. It has significant advantages for
therapeutic procedures, especially negotiating
upper oesophageal strictures and insertion of
nasoenteric feeding tubes.
Conclusions TNE is well tolerated and a valuable
diagnostic tool. Further evidence is required to
establish its accuracy for the diagnosis of early
and small gastric malignancies. There is an
emerging role for TNE in therapeutic endoscopy,
which needs further study.
A gastrointestinal (GI) endoscopic pro-
cedure is the first-line tool for detecting
GI pathology. Traditionally oesophago-
gastroduodenoscopy (OGD) is performed
by the transoral route, often with the
patient under conscious sedation; only
11% of procedures were performed
without sedation in the a previous British
Society of Gastroenterology (BSG) audit.1
Compared with local pharyngeal anaes-
thesia, sedation is associated with sub-
stantial cost and requires additional
monitoring, nursing staff and a recovery
area. Sedation is also associated with
some risk; the incidence of cardiopul-
monary events is estimated at 0.6%.2
Transnasal endoscopy (TNE) is per-
formed with an ultrathin (UT) endoscope
inserted via the nasal passages and is
becoming increasingly available. It is per-
formed unsedated so avoids sedation-
related complications and there is emer-
ging evidence that it also causes less sym-
pathetic stimulation leading to milder
cardiovascular stress.3 By virtue of its
route it also reduces pharyngeal stimula-
tion, which may be the reason for its
superior tolerability and therefore patient
satisfaction (see figure 1).
Thus, unsedated, TNE is an attractive
diagnostic method as it offers efficient
and accurate endoscopic assessment of
the oesophagus, stomach and duodenum
with less cost and fewer risks than
sedated upper GI endoscopy.4–14 Its use
has dramatically increased in Japan since
its introduction, but uptake has been
much slower in Europe.15
In this review, we elucidate the tech-
nical characteristics, tolerability, safety,
side effects and acceptability of this
method of upper gastrointestinal (UGI)
endoscopy. We will cover the diagnostic
accuracy of TNE and its possible use as a
screening tool as well as therapeutic
applications and future developments. We
also offer practical advice including tips
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from an ear, nose, throat (ENT) specialist to optimise
TNE practice.
TECHNICAL CHARACTERISTICS
UT endoscopes were initially designed for use in
paediatrics and have a shaft diameter of 6 mm or less
(range 4.9–6 mm), which allows them to be passed
through the nose. They are similar in design to stand-
ard endoscopes, although the diameter of the acces-
sory channel is only 2 mm (compared with 2.8 mm in
a standard gastroscope) and the working length ranges
from 1050 to 1100 mm. Some models, particularly
those with the smallest shafts, have two-way (up and
down) rather than conventional four-way tip deflec-
tion, but with the developments in CCD technology
the latest models have not only conventional four-way
tip deflection, but also a field of view of 120–140°
and image enhancement (flexible spectral imaging
colour enhancement (FICE)) capabilities. Due to a
smaller working channel, the sizes of biopsy samples
obtained with smaller diameter biopsy forceps are
smaller (1.8 mm compared with 2.2 mm) but they are
of comparable thickness; the smaller size has not been
found to significantly affect their diagnostic perform-
ance.16 17 The new generation of TNE scopes now
available offers a 2.4 mm channel allowing the
passage of standard biopsy forceps. There is some evi-
dence that using small diameter biopsy forceps for
rapid urease test results in significantly lower positive
rates although this can be eliminated by taking two
samples, thus increasing the amount of tissue to be
tested.17
There are some technical limitations of the UT
endoscope; its narrow diameter results in a more
floppy scope that can limit advancement especially in
patients with unusual or tortuous anatomy, although a
complete endoscopy is achieved by experienced users
in all but the most complex cases. A smaller working
channel also can result in limited suction, less effective
screen washing and fewer available endoscopic
accessories.
PRETREATMENT TECHNIQUES
The technique of unsedated TNE involves the applica-
tion of topical nasal anaesthesia and is performed
with the patient in the upright seated or left lateral
decubitus position (as for standard endoscopy). Once
topical anaesthesia has been performed, the endo-
scope is lubricated and passed through the nasal cavity
under direct visualisation into the posterior pharynx
(see box 1). Once the instrument is beyond the upper
oesophageal sphincter, endoscopy is performed in the
standard fashion.
TNE is generally recognised as a less painful endo-
scopic procedure,18–23 but the most commonly
reported discomfort is during the nasal insertion
phase of the procedure.20 24 Appropriate pretreatment
is therefore important, but there are limited data
regarding the optimal regimen and technique for
reducing discomfort. Shaker published the earliest
report on the use of 2% lidocaine gel delivered by a
cotton-tipped applicator to perform nasal anaesthe-
sia.25 Endoscopic-guided aerosolised spray (EGAS)
has also been used, but in one study using 4% lido-
caine nasal spray 33% of patients complained of nasal
pain during the prolonged procedure.26–28 Lee
recently reported a cotton pledget method of nasal
anaesthesia and compared this with EGAS with no sig-
nificant difference in visual analogue scores for pain
during nasal anaesthesia.29 Pain scores during inser-
tion were significantly lower in patients who received
the cotton pledget method; they also experienced less
throat pain after the examination, less gagging and
had better overall tolerance. There were no cases of
insertion failure, which may be due to more efficient
turbinate shrinkage with this method.30 Topical nasal
anaesthesia with local anaesthetic (LA) spray plus LA
stick in the nasal cavity plus pharyngeal anaesthesia
has been found to cause significantly less pain during
insertion of the endoscope.31 There does not appear
to be any additional benefit of adding a decongestant
such as xylometazoline to topical anaesthetic to
reduce discomfort, but does seem to improve nasal
insertion and reduce procedure time, likely due to tur-
binate shrinkage.32 Optimal pretreatment therefore
appears to be nasal and pharyngeal anaesthesia plus
use of decongestant, which should result in optimum
Figure 1 Differences in method of insertion between standard
and transnasal approach (diagram courtesy of Dr S Inglis).
Box 1 Ear, nose, throat tips for negotiating the
nasopharynx
▸ Passage through the nose can be disorientating so it
is wise to have a set method.
▸ Orientate the nasal passages vertically prior to
starting.
▸ Slow and careful passage through the nose should
be either below or above the inferior turbinate.
▸ Try and avoid contact with the nasal septum as this
is the most sensitive part of the nose.
▸ Ask the patient to breathe through the nose; this will
depress the soft palate opening up the nasopharynx
and making the correct line of passage more
obvious.
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nasal anaesthesia and ease of endoscope passage,
resulting in higher likelihood of successful transnasal
examination (see boxes 2 and 3).
PATIENT TOLERABILITY, SIDE EFFECTS AND
SAFETY
There are several studies comparing tolerance for
unsedated TNE and conventional transoral OGD
either with or without sedation. The majority of
these found better patient tolerance rates in the TNE
group based on patient tolerance question-
naires.8 18 20 22 33–36 Patients have greater satisfaction
and acceptability4 8 9 20 34–36 and are to be more
likely to undergo TNE in the future. They also report
a significant reduction in gagging20 37 and in some
studies discomfort22 34 (see table 1). One randomised
study that reported better overall satisfaction with
sedated conventional OGD also reported a significant
level of pain during insertion of the endoscope during
the transnasal procedure and also had a high failure
rate of TNE procedure due to failure to pass through
the nasal cavity at 22%.38 One comparative study
demonstrated good tolerance of both routes but again
found significantly more pain on insertion (1%
phenylephrine, 4% lidocaine nasal spray) with TN
route.39 Priess et al20 also found significantly more
pain on insertion but significantly less gagging and
significantly higher patient satisfaction. A recent study
evaluating TNE in the elderly (>70 years) found it is
safe and well accepted in this group.37
A recently published prospective randomised control
trial has demonstrated that the high tolerance and
acceptability reported mostly in trials from Southeast
Asia is also applicable to the UK population.40
Due to the subjective nature of any assessment of
patient tolerance and satisfaction, alternative methods
for assessing safety and tolerability would be prefer-
able. The assessment of cardiac function and oxygen
saturation are both objective methods of evaluating
safety and tolerability of endoscopic procedures.
Previous studies have shown that TNE causes fewer
adverse effects on cardiovascular function than trans-
oral OGD.36 40 41 It is also less stressful to the cardio-
vascular system with reduced elevation of systolic
blood pressure and less sympathetic stimulation than
the oral procedure.41 This may well be an important
factor as cardiovascular mortality has a significant
relationship with autonomic nervous function.
As TNE is performed without sedation, this source
of complications is eliminated. Rates of other compli-
cations are low and in the largest two series included
self-limited epistaxis (0.85–2%) and vasovagal events
(0.3%)34 42 A single oesophageal perforation was
reported.39 The main difficulty in performing the pro-
cedure is the inability to pass the endoscope transna-
sally due to narrow nasal tracts or altered anatomy in
3–8% of patients,20 34 42 for which there can be mul-
tiple reasons (see box 4).
No definitive guidelines exist for indications or con-
traindications, but it is not usually performed in those
with previous nasal trauma or surgery (although
unless this is recent and the introducer is passed
without problems, TNE should be possible) or a sig-
nificant coagulopathy. From an ENT point of view, a
history of frequent and problematic epistaxis would
be the most likely reason to avoid TNE. In particular,
patients with hereditary haemorrhagic telangiectasia
(HHT) have delicate nasal mucosa, which will bleed
on contact. If the nasal cavity otherwise looks straight-
forward for TNE passage, there should be no reason
to avoid it in patients taking anticoagulants. If epi-
staxis does occur, this is usually a straightforward
complication to manage (see box 5).
COST EFFECTIVENESS
TNE has been shown to have shorter procedure times
and lower procedure costs due to savings from avoid-
ing sedation and minimising the patient observation
period required post procedure.4 43 A shorter proced-
ure means more efficient flow of patients through the
endoscopy unit maximising cost efficiency. When
TNE is compared with endoscopy under pharyngeal
anaesthesia (throat spray), it has higher acceptance,
thus less likely for a TNE procedure to fail. Its good
safety profile means TNE does not require the
Box 3 Our practice for nasal preparation
▸ Lidocaine hydrochloride 5%, phenylephrine hydro-
chloride 0.5% spray is applied to both nostrils.
▸ A flexible plastic catheter is then lubricated with 2%
lidocaine gel (instillagel) and inserted into one
nostril.
▸ For ease of insertion, the patient’s head should be
kept in a neutral position and the catheter is inserted
aiming straight back towards the back of the head. If
any resistance is felt to passage, the process is aban-
doned and attempted on the other side.
▸ If it is not possible to insert the catheter, the proced-
ure is carried out transorally.
Box 2 Ear, nose, throat tips for assessing nasal
patency
▸ Occlude one nostril at a time and ask patient to
breathe through to see which is more patent.
▸ Use an auroscope with nasal speculum attached to
look up nose; this provides a rapid diagnosis of
septal deviation, inferior turbinate enlargement or
gross nasal polyposis.
▸ It is then possible to ensure the correct nostril is
prepared.
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presence of two nurses in the endoscopy room; the
potential for fewer endoscopy nurses to support a
TNE list reduces costs and increases the potential for
out-of-hours lists increasing patient convenience and
economic benefits resulting from a reduction in time
taken out of work for patients.
DIAGNOSTIC CAPABILITY
The diagnostic accuracy of TNE compared with stand-
ard gastroscopy has been examined in a variety of
scenarios. In previous literature, the diagnostic yield
had been found to be similar for the detection of
Barrett’s oesophagus (BO) and gastric cancer.5 44 45 It
has been found to have better performance than oral
OGD in the diagnosis of GORD-associated diseases in
one paper.46 There has been increasing focus recently
on the use of TNE as a screening tool especially for
BO and early gastric and oesophageal malignancies. It
use is also increasing for screening patients with docu-
mented aerodigestive tract tumours for coexisting
oesophageal squamous cell carcinomas (SCCs).47 48
With the increasing incidence of oesophageal adeno-
carcinoma (increased sevenfold over the last 35
years)49 and poor survival rates,50 screening for BO
has long been considered. Currently, screening of the
general population in the UK is not recommended;51 52
Table 1 Tolerability of TNE versus conventional OGD
Study Outcome measure used Reported outcome
Dean et al8 VAS—choking, discomfort, acceptability TNE more acceptable (p<0.05)
Campo et al18 VAS—discomfort, retching, pain, tolerance TNE better tolerated (p<0.05)
Dumortier et al21 VAS—pain, nausea, choking TNE less choking (p<0.05)
Garcia et al4 VAS—satisfaction No significant difference
Preiss et al20 VAS—gagging, pain, tolerance TNE less gagging (p<0.05)
Thota et al33 Tolerance score No significant difference
Murata et al22 Pain score—tolerance, discomfort TNE less discomfort (p=0.001)
TNE better tolerated (p=0.002)
Trevisani et al34 VAS—pain, discomfort
Tolerance score
TNE better tolerated
Zhang et al37 VAS—pain, discomfort, choking No significant difference
Choe et al67 VAS—satisfaction and tolerance TNE better tolerated (p=0.001)
OGD, oesophagogastroduodenoscopy; TNE, transnasal endoscopy; VAS, visual analogue scale.
Box 4 Reasons for failure of passage of the
endoscope
▸ Severe septal deviation will prevent passage of the
endoscope; however, the opposite side will almost
always be patent.
▸ Nasal polyposis; this is relatively common. In gross
disease, the patient will have obvious nasal obstruc-
tion and for less severe disease where polyps do not
reach the nasal floor scope passage should be
possible.
▸ There are some rare pathologies that may prevent
passage of the endoscope, which include Wegener’s
granulomatosis, neoplasms, meningoencephalocoeles
and choanal atresia.
Box 5 What to do if epistaxis occurs
▸ The most frequent site for epistaxis is at Little’s area,
which is the anterior nasal septum; direct pressure
over the lower third of nose for at least 5 min should
control the majority of minor bleeds caused by trans-
nasal endoscopy trauma.
▸ For patients whose epistaxis does not settle with
pressure, then either a tampon-type pack or a
balloon-type pack should be inserted. The key is to
insert it along the floor of the nose until the entire
pack is within the nasal cavity. The tampon-type
pack should be irrigated with 10 mL of water or
saline to make it swell. The balloon-type pack should
be inflated with air using the pilot balloon as a guide
to its internal pressure. Packing can be performed
bilaterally if unilateral packs do not control the
bleeding.
▸ In the rare event that bleeding is severe, appropriate
resuscitation and liaison with ear, nose, throat is
indicated.
▸ For patients with minor epistaxis, controlled with
pressure, the use of an antibiotic cream may prove
beneficial. Naseptin cream (contains chlorhexidine
and neomycin) is often prescribed for recurrent minor
epistaxis and following nasal cauterisation. It should
not be used in patients with peanut allergy. Other
options include Bactroban or Vaseline. The cream
should be sniffed off the patient’s finger into the
nostril and rubbed in by pressure from outside the
nose. Patients should be warned from causing digital
trauma.
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however, the emergence of endoscopic therapies for
BO may alter the economic viability of screening. Most
previous studies into accuracy of diagnosis of BO with
TNE were performed with the aim of looking at the
accuracy of detection of any upper GI lesions; they
consisted of very small numbers and were inconclusive
as to whether smaller endoscope size does limit diag-
nostic ability.7 10 12 53 54 Only two studies used a ran-
domised design and included BO as a randomised
endpoint. Jobe et al5 found only moderate agreement
(κ score=0.591); however, a more recent study
showed almost perfect agreement between TN and
standard OGD (κ score 0.94; 95% CI 0.85 to 1.00).45
It also found that dysplasia was detected by both
modalities with similar accuracy.
GASTRIC CANCER
In Japan, up to 60% of gastric cancers are diagnosed
as early cancers.55 In Western countries, however,
early disease is much less frequently detected account-
ing for between 10% and 20% of all gastric cancers.56
This difference can be partly explained by the mass
screening programme that exists in Japan. It is recog-
nised that there is a miss rate for gastric cancer with
standard endoscopy, and false negative rates have been
reported to be between 10% and 19%.57 It has also
been shown that for those diagnosed with early
gastric cancer endoscopically one out of six had had
an endoscopy within the previous three years.58 In the
UK, a recent abstract suggests that 14% of subjects
with gastric cancer have had an endoscopy in the
three years prior to their diagnosis.59 Early gastric
cancer is not recognised on endoscopy with appear-
ances being thought to be due to benign diagnoses
such as inflammation with cancer being found on hist-
ology. It is also recognised that fewer years of endo-
scopic experience had an impact on the diagnosis of
early gastric cancer and that early cancers in the
gastric cardia, especially the lesser curve or posterior
wall, are more likely to be overlooked.60
Various methods have been studied to attempt to
improve accuracy of endoscopic diagnosis of gastric
cancer with standard endoscopy. Magnifying endoscopy
with narrow-band imaging (M-NBI) used in combin-
ation with conventional white-light endoscopy results in
significantly enhanced performance in diagnostic yield
of early gastric cancer when compared with white-light
endoscopy alone. M-NBI is especially useful in making
an accurate diagnosis from endoscopic findings alone
even for small depressed gastric mucosa cancers.61
With regard to the use of TNE for the diagnosis of
gastric cancer, the literature has raised some potential
concerns especially relating to the accuracy of TNE in
detecting small or superficial, gastric malignant
lesions.5 34 50 An initial paper comparing the detec-
tion rate of early gastric cancer and adenoma with
TNE and transoral endoscopy found no significant
differences in diagnosis.44
Subsequent publications have revealed opposing
findings. One paper62 looking at the performance of
UT endoscopy for the diagnosis of superficial gastric
neoplasia shows that the diagnostic accuracy for
superficial gastric neoplasia is significantly lower for
UT endoscopy than for high-resolution standard
endoscopy with 25% of gastric neoplasia being missed
by UTendoscopy.
A second paper looking at use of TNE in screening
for early gastric cancer63 suggested that the diagnostic
utility of UT endoscopy was inadequate for the diag-
nosis of early gastric cancer lesions (<20 mm), espe-
cially those located in the upper third of the stomach;
the suggested explanation for this was lower reso-
lution and lower light intensity of the UT scope. The
authors also suggested that the diagnostic utility of
UTendoscopy can be improved by indigo carmine dye
spraying. Both trials included small numbers of
patients, but both indicate that the location of path-
ology is important, with UT endoscopy being more
likely to miss early pathology in the proximal stomach
but no significant difference in the pick-up rate for
pathology in the distal stomach. These studies only
studied UT endoscopy with white light. In contrast,
excellent detection rates for oesophageal and gastric
cancers have previously been reported when using UT
endoscopy in combination with chromoendoscopy
using indigo carmine and iodine.64 It has also been
suggested that if image enhancing techniques such as
NBI (or FICE) can be applied through a UT endo-
scope, this may be useful in improving the detection
of oesophageal premalignant lesions.65 This is now
possible with the latest series of UT scopes.
In Asian populations, there have been two studies
looking at the use of TNE to screen patients with
head and neck cancers for oesophageal SCCs. One
study looked at the yield of this procedure and found
that 10% of patients had oesophageal SCC diagnosed
by TNE and 7.3% had lesions with high-grade dyspla-
sis. They used both NBI and Lugol chromoendoscopy
and showed an increased pick-up rate when both NBI
and Lugol chromoendoscopy were used compared
with white light alone. Aiming for lesions that
appeared brownish under NBI or unstained under
Lugol chromoendoscopy had the highest sensitivity.47
A study on a similar patient population but compar-
ing white endoscopy with FICE and Lugol staining
did not show a significant difference between the two
methods and diagnosed 12.5% of patients with
oesophageal SCC.48
OESOPHAGEAL VARICES
TNE has been used to screen for oesophageal varices
in patients with cirrhosis, the detection and grading of
varices being equivalent to standard OGD in two
papers66 67 Saeian et al66 included only 15 patients,
those with a platelet count of <50 000 mm3 were
excluded and epistaxis rate was 6%. Choe et al67
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randomised 89 patients and had excellent concord-
ance rates (κ score=0.87). They reported an epistaxis
rate of 6%, and 28 patients had an international nor-
malised ratio of 1.7–2.3 and platelets between 20 000
and 50 000 mm3; this group had an epistaxis rate of
14%. Concerns exist about performing TNE in
patients with a coagulopathy, and this may be one of
the reasons why TNE has not been adequately
assessed as a screening tool for varices.
DIAGNOSIS OF ENT PATHOLOGY
Infrequently, coincidental pathology may be noted
within the upper aerodigestive system, so it is reason-
able to expect TNE practitioners to have some knowl-
edge of common ENT pathologies and pathways of
management. Findings such as simple nasal polyps
(see figure 2) would be appropriate to bring to the
attention of the patient and inform them to consult
their general practitioner. Suspected malignancies
would require urgent referral to ENT. Common sites
for aerodigestive tumours to be found with TNE are
within the nose, larynx and hypopharynx (see
figures 3 and 4); however, due to the swallowing
motion required to aid passage of the TN scope, TNE
is not an appropriate investigation for these areas as
small pathology is likely to be missed. Also, tumours
within the oropharynx are unlikely to be visualised.
Nasal masses that look anything other than benign
polyps warrant urgent ENT referral and likewise any
suspicion of laryngeal and hypopharyngeal tumours.
Laryngeal pathology is varied but is likely to ultim-
ately require biopsy to confirm a diagnosis.
FEASIBILITY AND SAFETY IN THE PRIMARY CARE
POPULATION
A recent paper from 2012 demonstrated the feasibility
and safety of TNE in a primary care population,
achieving short procedure times, a high diagnostic
yield and minimal anxiety. The findings suggested that
TNE has a similar ability to standard OGD to identify
upper GI pathology in this population, strengthening
argument for its consideration for use as screening
tool in the primary care population.68 The significant
improvement of optics and field of view (from 120°
to 140° similar to standard endoscopes) (see figures 5
and 6) of newer TNE endoscopes will most certainly
reduce the probability of missing pathology compared
with standard endoscopy, although comparative
studies are necessary to confirm this in the future.
THERAPEUTIC APPLICATIONS OF TNE
There is increasing literature on the use of UT scopes
for various therapeutic indications including, most
commonly, the insertion of feeding tubes. More
recently, UT scopes have been used in the treatment of
GI strictures (where the small diameter of the scope
aids in the placement of a wire across the stricture)
and to assist advanced endoscopic techniques such as
endoscopic submucosal dissection (ESD) and endo-
scopic retrograde cholangiopancreatography (ERCP).
Figure 2 Rigid endoscope showing benign polyps within the
right nasal cavity.
Figure 3 Right-sided glottic squamous carcinoma (viewed
under general anaesthesia with rigid laryngoscope).
Figure 4 Left-sided glottic granuloma (viewed under general
anaesthesia with rigid laryngoscope).
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Insertion of NET/PEG tubes
TNE is ideal for the placement of nasoenteral feeding
tubes (NET), especially nasojejunal (NJ) tubes (see
box 6). It was first used to place NET in critically ill
patients;69 its main benefits in this group are no
requirement for additional sedation, ability to
perform the procedure at the bedside and no radiation
exposure compared with fluoroscopy-assisted inser-
tions. In direct comparison to transoral endoscopic
placement, TN placement is significantly faster and
causes fewer cardiorespiratory complications.69
When compared with fluoroscopic insertion in crit-
ically ill or severe pancreatitis patients, TN placement
has equal success rates with a significantly shorter pro-
cedure time and less patient discomfort.70 71 It has
been shown that using an endoscope with a longer
working length 92 vs 133 cm significantly improves
success rates of insertion of NET.72 TNE is very
helpful in the placement of NET in a range of upper
GI diseases such as malignant strictures, gastric outlet
obstruction and gastroparesis,73 as well as nasogastric
tube placement in patients with oesophageal cancer.74
TNE has also been used successfully for the inser-
tion of percutaneous endoscopic gastrostomy (PEG)
tubes (the bumper is compressed and then passed
through the nose) and has a potentially important role
due to less sedation requirements and less cardiovas-
cular stress in patients likely to have significant
comorbidities. However, further studies are necessary
to establish its role and potential advantages over
transoral PEG placement.75 Currently, TNE-assisted
PEG insertions have been reserved for patients whom
conventional PEG placement is difficult such as in
cases of GI strictures or trismus (inability to fully
open mouth).76
Management of upper GI strictures
UT scopes have been used in patients with upper GI
strictures and can successfully traverse >80% of such
strictures, resulting in higher endoscopy completion
rates in such patients and enabling full characterisation
of the stricture (diameter, length and enabling biopsies
for histological diagnosis). Dilatation of such strictures
can be done safely as endoscopic placement of a guide-
wire is possible in most cases via an UTendoscope even
in tight strictures without the need for fluoroscopy.77
This is in line with the BSG guidelines that recommend
using a wire-guided technique for performing oesopha-
geal dilatations.78 Using the UT scope to place the wire
reduces the numbers of repeat procedures and reduces
the need for radiology support, therefore potentially
reducing costs, and so on.
ESD is increasingly used for the treatment of early
gastric cancer; however, difficulties can be encoun-
tered due to the location of the lesion. TNE has been
Box 6 Insertion of nasojejunal (NJ) tube with
transnasal endoscopy (TNE)
▸ TNE is performed in the usual manner.
▸ A guidewire is then inserted under direct vision into
the duodenum and advanced as far as possible into
the small bowel as with standard technique for inser-
tion of NJ tubes.
▸ The endoscope is withdrawn, leaving the wire in situ
and the NJ tube placed over the wire. In our experience,
this makes the technique simpler with no awkward fid-
dling with the wire at the back of the mouth.
▸ Post-pyloric placement of the feeding tube is then
confirmed endoscopically. A thinner endoscope also
seems to reduce the likelihood of pulling the feeding
tube back as the endoscope is withdrawn.
Figure 5 View of oesophagogastric junction for transnasal
endoscopy.
Figure 6 View of oesophagogastric junction for standard
endoscopy.
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used to enable easier access to lesions extending into
the antrum/pylorus or duodenal bulb wherein the TN
scope is used as an assistant scope to enable adequate
retraction of tissue to allow en bloc resection.79 80
Transnasal scopes have also been used to perform
ERCP; however, biliary cannulation has been found to
be more difficult and the size of the channel will limit
the availability of therapeutic accessories.81
Limitations of TNE
The thinner diameter of the TNE scope also produces
limitations as well as benefits; it is more likely to be
damaged than a standard endoscope. Due to its nar-
rower channel and lesser washing and suction, there
are limits to both visibility and available therapeutic
accessories, which means its use is limited as a thera-
peutic tool, especially in the context of upper GI
bleeding.
CONCLUSION
Although TNE has been available for more than a
decade, the technique is widely used in Japan, but its
use is variable in Europe and there are very little data
on the extent of its use in the UK. It has been sug-
gested from a previous European survey that reasons
for reluctance in use are concerns about diagnostic
accuracy and histological sampling as well as lack of
training.82 There is an increasing body of evidence
that TNE is a better tolerated procedure compared
with standard endoscopy per os, and the main area of
discomfort is nasal pain during insertion of the TNE
endoscope, which seems remediable with adequate
nasal and pharyngeal topical anaesthesia.
There are three areas where TNE has clear advan-
tage compared with standard OGD:
▸ its use as a screening tool for GI pathology;
▸ first-line use as a diagnostic tool in the elderly and those
with multiple comorbidities especially cardiovascular
disease;
▸ therapeutic procedures especially negotiating upper
oesophageal strictures and for the insertion of nasoen-
teric feeding tubes.
The tolerability and cost effectiveness in comparison
to oral OGD in a primary care population have been
demonstrated. TNE is an ideal tool for screening and
surveillance for UGI pathology such as Barrett’s (in
the Western world) or gastric cancer (in the East).
As discussed previously, there are miss rates for
early gastric cancer with standard endoscopy and cer-
tainly there have been concerns raised from the litera-
ture about the use of TNE, especially in the diagnosis
of early gastric cancer.
There are ways in which the technique of TNE may
be enhanced to improve the pick-up of early gastric
cancer. Adequate preparation of the gastric mucosa to
ensure views are not impaired by mucus especially in
TNE where views can potentially be a problem due to
reduced suction; asking patients to drink a mucolytic
and defoaming agent may be of use to improve views.
During the procedure, meticulous examination of the
gastric mucosa is required. Adequate insufflation is
vital to ensure that all the gastric mucosa can be
adequately visualised. To ensure all of the mucosa has
been examined especially in the ‘high-risk’ miss areas,
that is, the proximal stomach, the introduction of a
technique to ‘map’ the entire stomach as has been
developed in Japan83 may be helpful. This includes
photomapping and requires multiple photographs to
be taken; however, a variation of this from the
European Society of Gastrointestinal Endoscopy
requires only eight photographs and may be a more
practical approach to adopt.84 There should be con-
sideration given to procedure time as it has been
established that endoscopists who have longer proced-
ure times and take more than four pictures detect
more pathology than those with shorter procedure
times who take fewer pictures.85 Perhaps the consider-
ation of a withdrawal time as for colonoscopy should
be considered. That TNE is better tolerated makes it
an ideal tool to ensure meticulous examination as
longer procedures will be better tolerated. When
abnormal areas are discovered, the use of indigo
carmine and NBI may be helpful in characterising
them. Many of the ways in which pick-up rates of
early gastric cancer may be improved can be applied
to both TNE and conventional upper GI endoscopy.
Further evidence is still required to establish the
accuracy for TNE for the diagnosis of early and small
gastric malignancies and ideally these would be
studies performed in Western populations. Another
factor that needs to be considered is the continuing
evolution of technology with the availability of new
endoscopes. These endoscopes now have an increased
field of view at 140°, superior image quality and the
routine use of image enhancing techniques such as
NBI or FICE, as well as chromoendoscopy. They also
have better suction and water jet and an increased size
of biopsy channel. These technical improvements as
well as changes in technique of examination should
almost certainly help to improve the diagnostic accur-
acy of TNE for early gastric malignancies.
TNE can certainly be used in the diagnosis of
oesophageal varices, although there are limited studies
at present. Given the increasing incidence of chronic
liver disease, TNE is a useful modality for variceal
screening. More guidance regarding absolute contrain-
dications with regard to levels of coagulopathy accept-
able for performing TNE is currently lacking; it
would be seen from ENT practice (although the ENT
scope is thinner) that unless there is a history of recur-
rent epistaxis or HHT there is no reason for anticoa-
gulation to be an absolute contraindication to TNE.
TNE has benefit in terms of cardiovascular stress,
which translates to great advantages in patients with
multiple comorbidities, particularly pre-existing car-
diorespiratory disease, and in the elderly. There is also
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an emerging role for TNE in therapeutic endoscopy.
Such use needs further study and development of
appropriate accessories to increase its therapeutic
potential. It is expected that the latest generation of
TNE scopes in addition to better image definition and
colour enhancement may also accommodate a larger
biopsy channel (2.2 mm), which will increase the
therapeutic ability of such scopes.
The reason for preventing widespread use of TNE
may be the lack of formal training and accreditation
for this technique in the UK, which may also contrib-
ute to the reluctance to use this technique.86 This
raises the question of how endoscopists should be
trained in the use of TNE. The authors would suggest
the development of dedicated TNE training as part of
existing upper GI basic skills courses or as a
stand-alone course. ENT specialists should be involved
to emphasise the important aspects of the anatomy of
the nasopharynx and recognition of common but sig-
nificant nasopharyngeal pathology, and finally, to
advise on how to achieve successful nasal intubation
as well as guidance on managing nasal complications.
Guidelines for training and accreditation, as exist for
standard endoscopy, should be developed for TNE.
Contributors CP performed the literature review, gathered and
reviewed the relevant literature and wrote the paper. EA
assisted in writing the paper. JP supervised the work and
assisted with writing and review of the paper. JO provided
images and expertise for the ENT parts of the paper. SP
supervised the work and assisted in writing and review of the
paper.
Competing interests CP was in an endoscopy fellow post
financially supported by Imotech Medical UK. EA’s previous
fellowship and trial in Transnasal Endoscopy was supported by
Fujifilm/Imotech Medical UK. JP was principal investigator for
transnasal trial previously financially supported by Fujifil/
Imotech Medical UK. SP is supervisor to endoscopy fellowship
financially supported by Imotech Medical UK. JO, JP and SP
have taught on TNE course supported by Imotech Medical UK.
Provenance and peer review Not commissioned; externally
peer reviewed.
REFERENCES
1 Quine MA, Bell GD, McCloy RF, et al. Prospective audit of
upper gastrointestinal endoscopy in two regions of England:
safety, staffing and sedation methods. Gut 1995;36:462–7.
2 Sharma VK, Nguyen CC, Crowell MD. A national study of
cardiopulmonary unplanned events after GI endoscopy.
Gastrointest Endosc 2007;66:27–34.
3 Mori A, Ohashi N, Tatebe H. Autonomic nervous function in
upper GI endoscopy: a prospective randomised comparison
between transnasal and oral procedures. J Gastroenterol
2008;43:38–44.
4 Garcia RT, Cello JP, Nguyen MH. Unsedated ultrathin EGD is
well accepted when compared with conventional sedated EGD:
a multicentre randomised trial. Gastroenterology
2003;125:1606–12.
5 Jobe BA, Hunter JG, Chang EY. Office-based unsedated small
caliber endoscopy is equivalent to conventional sedated
endoscopy in screening and sureveillance for Barretts
esophagus: a randomised and blinded comparison. Am J
Gastroenterol 2006;101:2693–703.
6 Saeian K, Staff DM, Vasilopoulos S. Unsedated transnasal
endoscopy accurately detects Barretts metaplasia and dysplasia.
Gastrointest Endosc 2002;56:472–8.
7 Mokhashi MS, Wildi SM, Glenn TF. A prospective, blinded
study of diagnostic esophagoscopy with a superthin,
stand-alone, batterypowered esophagoscope. Am J
Gastroenterol 2003;98:2383–9.
8 Dean R, Dua K, Massey B. A comparative study of unsedated
transnasal esophagogastroduodenoscopy and conventional
EGD. Gastrointest Endosc 1996;44:422–4.
9 Mori A, Ohashi N, Yoshida A. Unsedated transnasal
esophagogastroduodenoscopy may provide better diagnostic
performance on gastroesophageal reflux disease. Dis Esophagus
2011;24:92–8.
10 Catanzaro A, Faulx A, Pfau PR. Accuracy of a narrow-diameter
battery-powered endoscope in sedated and unsedated patients.
Gastrointest Endosc 2002;55:484–7.
11 Faulx AL, Catanzaro A, Zyzanski S. Patient tolerance and
acceptance of unsedated ultrathin esophagoscopy. Gastrointest
Endosc 2002;55:620–3.
12 Catanzaro A, Faulx A, Isenberg GA. Prospective evaluation of
4 mm diameter endoscopes for esophagoscopy in sedated and
unsedated patients. Gastrointest Endosc 2003;57:300–4.
13 Faulx A, Vela S, Das A. The changing landscape of practice
patterns regarding unsedated endoscopy and propofol use:
a national web survey. Gastrointest Endosc 2005;62:9–15.
14 Boolchand V, Faulx A, Das A. Primary care physician attitudes
toward endoscopic screening for GORD symptoms and unsedated
esophagoscopy.Gastrointest Endosc 2006;63:228–33.
15 Tatsumi Y, Harada A, Matsumoto T. Current status and
evaluation of transnasal esophagogastroduodenoscopy.
Dig Endosc 2009;21:141–6.
16 Walter T, Chesnay AL, Dumortier J. Biopsy specimens obtained
with small caliber endoscopes have comparable diagnostic
performances than those obtained with conventional
endoscopes: a prospective study on 1335 specimens. J Clin
Gastroenterol 2010;44:12–17.
17 Jeon SJ, Shin SJ, Lee KM. Can the 1.8 mm transnasal biopsy
forceps instead of standard 2.2 mm alter rapid urease test and
histological diagnosis?. J Gastroenterol Hepatol 2012;27:1384–7.
18 Campo R, Monserrat A, Brullet E. Transnasal gastroscopy
compared to conventional gastroscopy: a randomised study of
feasibility, safety and tolerance. Endoscopy 1998;30:448–52.
19 Miyawaki T, Nose M, Kouzu T. Transnasal upper GI
endoscopy: safe and painless examination. Endosc Dig
2007;19:529–35.
20 Preiss C, Charlton JP, Schumacher B, et al. A randomised trial
of unsedated transnasal small caliber EGD versus peroral
small-caliber EGD versus conventional EGD. Endoscopy
2003;35:641–6.
21 Dumortier J, Ponchon T, Scoazec JY. Prospective evaluation of
transnasal oesophagogastroduodenoscopy: feasibility and study
on performance and tolerance. Gastrointest Endosc
1999;49:285–91.
22 Murata A, Akahori K, Sumida Y. Prospective randomised trial
of transnasal versus peroral endoscopy using ultrathin
videoendoscope in unsedated patients. J Gastroenterol Hepatol
2007;22:482–5.
23 Yagi J, Adachi K, Arima N. A prospective comparative study on
the safety and tolerability of transnasal EGD. Endoscopy
2005;37:1226–31.
ENDOSCOPY
Parker C, et al. Frontline Gastroenterology 2015;0:1–11. doi:10.1136/flgastro-2015-100589 9
group.bmj.com on July 19, 2016 - Published by http://fg.bmj.com/Downloaded from 
24 Cheung J, Bailey R, Veldhuyzen van Zanten S, et al. Early
experience with unsedated ultrathin 4.9 mm transnasal
gastroscopy: a pilot study. Can J Gastroenterol 2008;22:917–21.
25 Shaker R. Unsedated trans-nasal
pharyngoesophagogastroduodenoscopy (T-EGD) technique.
Gastrointest Endosc 1994;40:346–8.
26 Hu CT. Endoscopic guided versus cotton tipped applicator
methods of nasal anaesthesia for transnasal EGD: a randomised,
prospective controlled study. Am J Gastroenterol
2008;103:1114–21.
27 Maffei M, Dumonceau JM. Endoscopic guided versus cotton
tipped applicator methods of nasal anaesthesia for transnasal
EGD. Am J Gastroenterol 2008;103:3209; author reply 3209–10.
28 Itoi T, Kawai T, Sofuni A. Efficacy and safety of one-step
transnasal endoscopic nasobiliary drainage for treatment of
acute cholangitis in patients with previous endoscopic
sphincterotomy. Gastrointest Endosc 2008;68:84–90.
29 Lee YC, Wang CP. Cotton pledget method for nasal
decongestive anaesthesia prior to transnasal endoscopy. Am J
Gastroenterol 2008;103:3212–13.
30 Hu CT. Gauze pledgeting versus endoscopic-guided aerosolised
spray for nasal anaesthesia before transnasal EGD: a prospective,
randomised study.Gastrointest Endosc 2010;71:11–20.
31 Iwamoto J, Mizokami Y, Shimokobe K. Pretreatment methods
in transnasal endoscopy. Hepatogastroenterology
2011;58:842–5.
32 Cheung J, Goodman KJ, Veldhuyzen van Zanten S. CANHelp
working group, a randomised trial of topical anaesthesia
comparing lidocaine versus lidocaine plus xylometazoline for
unsedated transnasal upper gastrointestinal endoscopy. Can J
Gastroenterol 2010;24:317–21.
33 Thota PN, Zuccaro G, Vargo JJ. A randomised prospective trial
comparing unsedated esophagoscopy via transnasal and transoral
routes using a 4 mm video endoscope with conventional
endoscopy with sedation. Endoscopy 2005;37:559–65.
34 Trevisani L, Cifala V, Sartori S. Unsedated ultrathin upper
endoscopy is better than conventional endoscopy in routine
outpatient gastroenterology practice: a randomised trial. World
J Gastroenterol 2007;13:906–11.
35 Stroppa I, Grasso E, Paoluzi O. Unsedated transnasal versus
transoral sedated upper gastrointestinal endsocopy: a one-series
prospective study on safety and patient acceptability. Dig Liver
Dis 2008;40:767–75.
36 Mori A, Ohashi N, Maruyama T, et al. Cardiovascular
tolerance in upper GI endoscopy using an ultrathin scope:
prospective randomised comparison between transnasal and
transoral procedures. Dig Endosc 2008;20:79–83.
37 Zhang Q, Xioa AH, Tan XP. Ultrathin transnasal
esophagogastroduodenoscopy in geriatric patients: a
prospective evauation. Int J Gerontol 2011:217–21.
38 Birkner B, Fritz N, Schatke W. A prospective randomised
comparison of unsedated ultrathin versus standard
esophagogastricduodenoscopy in routine outpatient
gastroenterology practice: does it work better through the
nose? Endoscopy 2003;35:647–51.
39 Zaman A, Hahn M, Hapke R. A randomised trial of peroral
versus transnasal unsedated endoscopy using an ultrathin
videoendoscope. Gastrointest Endosc 1999;49:279–84.
40 Alexandridis E, Inglis S, McAvoy NC, et al. Randomised
clinical study: comparison of acceptability, patient tolerance,
cardiac stress and endoscopic views in transnasal and transoral
endoscopy under local anaesthetic. Aliment Pharmacol Ther
2014;40:467–76.
41 Mori A, Fushimi N, Asano T. Cardiovascular tolerance in
unsedated upper GI endoscopy: prospective randomised
comparison between transnasal and conventional oral
procedures. Dig Endosc 2006;18:282–7.
42 Dumortier J, Napoleon B, Hedelius F. Unsedated transnasal
EGD in daily practice: results with 1100 consecutive patients.
Gastrointest Endosc 2003;57:198–204.
43 Gorelick AB, Inadomi JM, Barnett JL. Unsedated small caliber
esophagogastroduodenoscopy (EGD): less expensive and less
time consuming than conventional EGD. J Clin Gastroenterol
2001;33:210–14.
44 Yoshida Y, Hayami Y, Matuoka M. Comparison of detection
rate of early gastric cancer and gastric adenoma using
transnasal EGD and that of transoral EGD. Dig Endosc
2008;20:184–9.
45 Shariff MK, Bird-Lieberman EL, O’Donovan M. Randomised
crossover study comparing the efficacy of transnasal endoscopy
with that of standard endoscopy to detect Barretts esophagus.
Gastrointest Endosc 2012;75:954–61.
46 Mori A, Ohashi N, Yoshida A. Unsedated transnasal ultrathin
esophagogastroduodenoscopy may provide better diagnostic
performance on gastroesophgeal reflux disease. Dis Esophagus
2011;24:92–8.
47 Wang CH, Lee YC, Wang CP. Use of transnasal endoscopy for
screening of esophageal squamous cell carcinoma in high risk
patients: yield, completion rate and safety. Dig Endosc
2014;26:24–31.
48 Arantes V, Albuquerque W, Salles JM. Effectiveness of
unsedated transnasal endoscopy with white light flexible
spectral imaging and color enhancement and lugol staining for
esophageal cancer screening in high risk patients. J Clin
Gastroenterol 2013;47:314–21.
49 Pohl H, Sirovich B, Welsh HG. Esophgeal adenocarcinoma
incidence: Are we reaching the peak? Cancer Epidemiol
Biomarkers Prev 2010;19:1468–70.
50 Eloubeidi MA, Mason AC, Desmond RA. Temporal trends
in survival of patients with esophageal adenocarcinoma
in the US: a glimmer of hope? Am J Gastroenterol
2003;98:1627–33.
51 Fitzgerald RC, Di Pietro M, Ragunath K, et al. BSG guidelines
of the diagnosis and management of Barretts oesophagus. Gut
2014;63:7–42.
52 Wang KK, Sampliner RE. Updated guidelines 2008 for the
diagnosis, surveillance and therapy of Barretts oesophagus.
Gastroenterology 2011;140:1084–91.
53 Sorbi D, Gostout CJ, Henry J. Unsedated small calibre
oesophagogastricduodenoscopy (EGD) versus conventional
EGD: a comparative study. Gastroenterology
1999;117:1301–7.
54 Wildi SM, Wallace MB, Glenn TF. Accuracy of esophagoscopy
performed by a non-physician endoscopist with a 4 mm
diameter battery-powered endoscope. Gastrointest Endosc
2002;56:472–8.
55 Hisamichi S. Screening for gastric cancer. World J Surg
1989;13:31–7.
56 Sue-Ling HM, Martin I, Griffith J, et al. Early gastric cancer:
46 cases in one surgical department. Gut 1992;33:1318–22.
57 Hosokawa O, Tsuda S, Kidani E. Diagnosis of gastric cancer up
to 3 years after negative upper gastrointestinal endoscopy.
Endoscopy 1998;30:669–74.
58 Suvakovic Z, Bramble MG, Jones R, et al. Improving the
detection rate of early gastric cancer requires more than open
access gastroscopy: a five year study. Gut 1997;41:308–13.
ENDOSCOPY
10 Parker C, et al. Frontline Gastroenterology 2015;0:1–11. doi:10.1136/flgastro-2015-100589
group.bmj.com on July 19, 2016 - Published by http://fg.bmj.com/Downloaded from 
59 Menon S, Dhar A, Hoare J, et al. How commonly is gastric
cancer missed at endoscopy: a UK primary care based study.
Gut 2012;61:A43.
60 Ren W, Yu J, Wang L. Missed diagnosis of early gastric cancer
or high grade intraepithelial neoplasia. World J Gastroenterol
2013;19:2092–6.
61 Ezoe Y, Muto M, Uedo N. Magnifying narrowband imaging is
more accurate than conventional white-light imaging in diagnosis
of gastric mucosal cancer.Gastroenterology 2011;141:2017–25.
62 Toyoizumi H, Kaise M, Arakawwa H. Ultrathin endoscopy
versus high-resolution endoscopy for diagnosing superficial
gastric neoplasia. Gastrointest Endosc 2009;70:240–5.
63 Hayashi Y, Yamamoto Y, Suganuma T. Comparison of the
diagnostic utility of teh ultrathin endoscope and the
conventional endoscope in early gastric cancer screening.
Dig Endosc 2009;21:116–21.
64 Kawai T, Yamagishi T, Moriyasu. Diagnosis of esophageal and
gastric carcinoma using ultrathin esophagogastricduodenoscopy.
In: Niwa, Tajiri, Nakajima, Yasuda, eds. New Challen in
Gastrointestinal Endoscopy. Springer, 2008:79–86.
65 Kawai T, Takagi Y, Yamamoto K. Narrow-band imaging on
screening of esophgeal lesions using an ultrathin transnasal
endoscopy. J Gastroenterol Hepatol 2012;27:34–9.
66 Saeian K, Staff DM, Knox J. Unsedated transnasal endoscopy:
a new technique for accurately detecting and grading
esophageal varices in cirrhotic patients. Am J Gastroenterol
2002;97:2246–9.
67 ChoeWH, Kim JH, Ko SY. Comparison of transnasal small-
caliber versus peroral conventional esophagogastricduodenoscopy
for evaluating varices in unsedated cirrhotic patients. Endoscopy
2011;43:649–56.
68 Peery A, Hoppo T, Garman K. Feasibility, safety, acceptability
and yield of office-based screening transnasal endoscopy (with
video). Gastrointest Endosc 2012;75:945–53.
69 Kulling D, Bauerfeind P, Fried M. Transnasal versus transoral
endoscopy for the placement of nasoenteral feeding tubes in
critically ill patients. Gastrointest Endosc 2000;52:506–10.
70 Fang J, Hilden K, Holugkov R. Transnasal endoscopy versus
fluroscopy for the placement of nasoenteric feeding tubes in
critically ill patients. Gastrointest Endosc 2005;62:661–6.
71 Zhihui T, Wenkui Y, Weiqin L. A randomised clincial trial of
transnasal endoscopy versus fluroscopy for the placement of
nasojejunal feeeding tubes in patients with severe acute
pancreatitis. Postgrad Med J 2009;85:59–63.
72 Wildi SM, Gubler C, Vavricka S. Transnasal endoscopy for the
placement of nasoenteral feeding tubes: does the working
length of the endoscope matter? Gastrointest Endosc
2007;66:225–9.
73 Zhang L, Huang Y, Yao W. Transnasal
esophagogastricduodenoscopy for placement of nasenteric
feeding tubes in patients with severe upper gastrointestinal
diseases. J Dig Dis 2012;13:310–15.
74 Cheung-Hui I, Nai-Jen L, Ching-Song L. Nasogastric feeding
tube placement in patients with esophageal cancer: application
of ultrathin transnasal endoscopy. Gastrointest Endosc
2006;64:104–7.
75 Dumortier J, Lapalus M, Pereira A. Unsedated transnasal PEG
placement. Gastrointest Endosc 2004;59:54–7.
76 Ogata T, Shimazu M, Sumi T. Percutaneous endoscopic
gastrostomy using an ultra-thin transnasal endoscope for
patients with trismus or GI stenosis. Dig Endosc
2009;21:A35.
77 Aydinli M, Koruk I, Dag MS. Ultrathin endoscopy for
gastrointestinal strictures. Dig Endosc 2012;24:150–3.
78 Riley SA, Attwood SEA. Guidelines on the use of oesophageal
dilatation in clinical practice. Gut 2004;53:i1–i16.
79 Nakamura M, Shibata T, Tahara T. Usefulness of transnasal
endoscopy where endoscopic submucosal dissection is difficult.
Gastric Cancer 2011;14:378–84.
80 Ahn JY, Choi KD, Lee JH. Is transnasal endoscope-assisted
endoscopic submucosal dissection for gastric neoplasm useful
in training beginners? Surg Endosc 2013;27:1158–65.
81 Mori A, Ohashi N, Maruyama T. Transnasal endoscopic
retrograde cholangiopancreatography using an ultrathin
endoscope: a prospective comparison with a routine oral
procedure. World J Gastroenterol 2008;14:1514–20.
82 Dumonceau JM, Dumortier J, Deviere J, et al. Transnasal
OGD: practice survey and impact of a live video
retransmission. Dig Liver Dis 2008;40:776–83.
83 Yao K. The endoscopic diagnosis of early gastric cancer.
Ann Gastroenterol 2013;26:11–22.
84 Rey JF, Lambert R. ESGE recommendations for quality control
in gastorintestinal endoscopy: guidelines for image
documentation in upper and lower GI endoscopy. Endoscopy
2001;33:901–3.
85 The J, Hartman M, Lau L. Duration of endoscopic
examination significantly impacts detection rates of neoplastic
lesions during diagnostic upper endoscopy. Gastrointest Endosc
2011;73:AB393.
86 Parker C, Panter S. Transnasal Endoscopy in the Northern
REgion-Survey to assess availability and opinion of TNE. Gut
2013;62:A265–66.
ENDOSCOPY
Parker C, et al. Frontline Gastroenterology 2015;0:1–11. doi:10.1136/flgastro-2015-100589 11
group.bmj.com on July 19, 2016 - Published by http://fg.bmj.com/Downloaded from 
Transnasal endoscopy: no gagging no panic!
Simon Panter
Clare Parker, Estratios Alexandridis, John Plevris, James O'Hara and
 published online July 2, 2015Frontline Gastroenterol 
 http://fg.bmj.com/content/early/2015/07/02/flgastro-2015-100589
Updated information and services can be found at: 
These include:
References
 #BIBL
http://fg.bmj.com/content/early/2015/07/02/flgastro-2015-100589
This article cites 84 articles, 9 of which you can access for free at: 
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on July 19, 2016 - Published by http://fg.bmj.com/Downloaded from 
